← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bavarian Nordic A/S
$14,958,758
Total funding
6
Grants
Funding over time
peak $4.9M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,416,447 · 5
DOD$1,542,311 · 1
By mechanism
N01$13,416,447 · 5
—$1,542,311 · 1
Investigators at Bavarian Nordic A/S
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine$4,850,824
N01 · FY2008 · AI
Development of Technologies that Accelerate the Immune Response to Vaccines$4,427,541
N01 · FY2012 · AI
DEVELOPMENT OF TECHNOLOGIES THAT ACCELERATE THE IMMUNE RESPONSE TO BIODEFENSE VACCINES$3,593,334
N01 · FY2014 · AI
EVALUATION OF THE SAFETY AND EFFICACY OF A VIRUS-LIKE PARTICLE VACCINE FOR PREVENTION OF CHIKUNGUNYA VIRUS DISEASE$1,542,311
· FY2022 · Defense Health Agency
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine$544,748
N01 · FY2013 · AI
DEVELOPMENT AND TESTING OF A MODIFIED VACCINIA ANDARA (MVA)-26630016$0
N01 · FY2003 · AI
DEVELOPMENT AND TESTING OF A MODIFIED VACCINIA ANDARA /MVA/-266-266030016$0
N01 · FY2004 · AI
PRODUCTION AND TESTING OF A MODIFIED VACCINIA ANKARA /MVA/ VACCINE.-266000072$0
N01 · FY2006 · AI
Development and Testing of a Modified Vaccinia Ankara /MVA/ Vaccine-266030016$0
N01 · FY2005 · AI
Production and Testing of a MVA Vaccine-266040072$0
N01 · FY2005 · AI